Avita Medical | 1811094D - Operating Profit



Avita Medical reported AUD-9957000 in Operating Profit for its fiscal semester ending in December of 2024.


Operating Profit Change Date
Adcock Ingram Holdings ZAR 487.33M 8.25M Dec/2024
Celltrion KRW 242.47B 94.87B Jun/2025
Clinuvel Pharmaceuticals AUD 39.05M 21.49M Jun/2024
Cochlear AUD 274.6M 54.5M Dec/2024
CSL USD 1.98B 778M Dec/2024
Cspc Pharmaceutical CNY 1.79B 940.51M Mar/2025
Dianthus Therapeutics USD -34927000 3.01M Jun/2025
Divis Laboratories Ltd 6.17B 1.62B Jun/2025
Kangmei Pharma CNY 16.43M 3.34M Jun/2025
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Laboratorios Farma EUR 27.37M 95.7M Jun/2025
Malin Corporation EUR -1100000 400K Dec/2024
Mayne Pharma AUD -3300000 15.67M Jun/2024
Medical Developments International AUD 182K 20.42M Dec/2024
Nanosonics AUD 8.7M 6.12M Dec/2024
Neuren Pharmaceuticals AUD 176.69M 166.79M Dec/2024
Organigram Holdings CAD -2100000 9.2M Jun/2025
Pacific Edge NZD -15314000 7.45M Sep/2024
Paradigm Biopharmaceuticals AUD -5930700 3.79M Dec/2024
Pharma Mar EUR 24.11M 27.19M Jun/2025
Polynovo AUD 513K 902K Jun/2024
PYC Therapeutics AUD -25891160 14.18M Dec/2024
Qiagen NV USD 135.97M 10.81M Jun/2025
Ramsay Health Care AUD 200M 285.4M Dec/2024
ResMed USD 456.57M 39.33M Jun/2025
Sartorius EUR 161.8M 24.4M Jun/2025
Sino Biopharmaceutical CNY 1.33B 2.53B Dec/2024
Telix Pharmaceuticals AUD 17.72M 24.27M Dec/2024
Tilray USD -42218000 5.65M Nov/2024
Zz Pientze Pharmaceu 553.87M 632.12M Jun/2025